PharmaMar collaboration activities with the following patients associations
Search Location
Presencia Internacional: 0
Loading...|
More information about the collaborations
|
|
Methodological notes
|
More information about the collaborations
More information about the collaborations
More information about the collaborations
Oncology pipeline
PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage drug candidates under development for several types of solid and hematological cancers, Aplidin ®, Lurbinectedin, and PM184.
Shareholders and Investors
Financial Information of the Company, stock information, official notices to the CNMV (Spanish Securities & Exchange Commission), product portfolio and other information.
Newsroom
If you need information about the company, our clinical trials, corporate images or multimedia, visit our newsroom
